AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LALANNE, C. M.
Right arrow Articles by LEFUR, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LALANNE, C. M.
Right arrow Articles by LEFUR, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

TELECOBALT THERAPY FOR CARCINOMA OF LARYNGOPHARYNX

C. M. LALANNE , Y. CACHIN , G. JUILLARD , and R. LEFUR

1. In small lesions, T1 and T2, of the laryngopharynx, telecobalt therapy gives as good results as the combination of surgery anti pre- and postoperative telecobalt therapy.

2. On the other hand, in larger lesions, T3 and T4, surgery supplemented by radiotherapy seems to be the best treatment.

3. Surgery after telecobalt therapy in carcinoma of the laryngopharynx is difficult. This must be kept in mind when designing a preoperative irradiation program. The dose in curable lesions should not exceed 3,000 r, with a weekly dose of 1,000 r.

4. Radiosensitivity of laryngopharynx cancers varies greatly from one patient to another. However, the best chance of cure is afforded by doses between 6,500 and 7,500 r.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the American Roentgen Ray Society.